1 option
Pharmacoeconomic review report : indication: treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies. Ustekinumab (Stelara/Stelara I.V.) Janssen Inc / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author, issuing body.
- Language:
- English
- Subjects (All):
- Gastroenterology--Decision making.
- Gastroenterology.
- Gastroenterology--History.
- Physical Description:
- 1 online resource
- Edition:
- Version: Final.
- Place of Publication:
- Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, 2020.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.